BSE filing, NSE: SYSTMTXC. Summary written from the filing by ALFA Finder's alert engine.
Systematix Corporate Services Ltd: key numbers
- Share price
- ₹76.80
- Market cap
- ₹1,049 Cr
- Revenue (annual)
- ₹146.2 Cr
- Net profit (annual)
- ₹13.85 Cr
- P/E (TTM)
- -698.2×Sector 19.7×
- Promoter holding
- 70.58%+0.00% QoQ
- FII holding
- 4.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Systematix Corporate Services Ltd
All →Systematix Corporate Services Other Announcement
Systematix Corporate Services Ltd has filed its quarterly shareholding pattern for the period ended 30th September 2026 as per Regulation 31 of SEBI LODR.
Systematix Corporate Services Merger & Restructuring Worth ₹10 Cr
Systematix Corporate Services will invest ₹10 Crore in its wholly-owned subsidiary, Systematix Wealth & Asset Services, by subscribing to a rights issue of equity shares.
- Value
- ₹10.00 Cr
Systematix Corporate Services Acquisition Worth ₹10 Cr
Systematix Corporate Services is investing ₹10 Crore via rights issue into its wholly-owned subsidiary, Systematix Wealth & Asset Services, for its working capital requirements.
- Value
- ₹10.00 Cr
Systematix Corporate Services Capital Structure Change
Systematix Corporate Services invested Rs. 10 Crore via a rights issue in its wholly-owned subsidiary, Systematix Wealth & Asset Services, to support working capital.
- Value
- ₹10.00 Cr
Systematix Corporate Services Management Change
Systematix Corporate Services declared a final dividend of Rs. 0.10 per share and re-appointed Mr. Nikhil Khandelwal as Managing Director for three years.
Systematix Corporate Services Annual General Meeting
Systematix Corporate Services held its 41st AGM on 22 Sep 2026, approving FY26 financials, a 10 paise dividend, and MD re-appointment. Routine governance resolutions were passed without member queries.
Other results update announcements
All →Indostar Capital Finance Results Update
IndoStar reported Q2 FY27 standalone results, with disbursements up 51% YoY to ₹1,399 crore. Profit after tax rose to ₹13.1 crore and AUM reached ₹8,459 crore.
Alivus Life Sciences Results Update
Alivus Life Sciences reported Q2FY27 revenue of Rs. 6,820 Mn (up 16.0% YoY) and PAT of Rs. 1,968 Mn in a press release. Investors see record EBITDA margins of 41.8% and capex progress at Solapur and Taloja.
Asset Reconstruction Company (India) Results Update
ARCIL's H1FY27 release shows total income up 48% to Rs.516.4 crore and PAT up 54% to Rs.290.0 crore. Investors should view performance over a longer horizon.
Capital Small Finance Bank Results Update
Capital SFB's Q2 FY27 PAT rose 30.7% year-on-year to ₹45.61 crore, while advances grew 23.4%. Asset quality improved, with GNPA at 2.36% and NNPA at 1.12%.
Strides Pharma Science Results Update
Strides Pharma reported Q2FY27 revenue of ₹14,297m, up 17.1% YoY, and EBITDA of ₹2,509m, up 8.4%, in a press release. Reported PAT rose 2.0% to ₹1,341m.
Fiberweb (India) Results Update
Fiberweb India's Q2 FY27 press release shows total income of ₹30.99 crore, up 209.36% quarter-on-quarter. Net profit rose to ₹1.27 crore.